AAN 2011: Laquinimod Reduces Relapses in Multiple Sclerosis
Links shared publicly online about this topic.
- 363total visits
AAN 2011: Laquinimod Reduces Relapses in Multiple Sclerosis
View full resource at hcplive.com
Tags: Multiple Sclerosis
Most Recently Shared on April 15, 2011 at 3:44 pm By:
#AAN2011 oral laquinimod reduces the annual relapse rate in patients with relapsing-remitting #multiplesclerosis http://hcp.lv/eBKzu6
Medical News: AAN: Laquinimod Cuts Relapses, Progression in MS - in Meeting Coverage, AAN from MedPage Today
medpagetoday.com — “HONOLULU -- The investigational drug laquinimod, in development for treating relapsing-remitting multiple sclerosis, reduced the relapse rate as well as disease progression in a placebo-controlled pha” View full resource at medpagetoday.com
Most Recently Shared on August 16, 2011 at 7:53 pm By:
Roger D. Jones, PhD Doctor, Health Executive, Health Social Media, and PhD
AAN: Laquinimod Cuts Relapses, Progression in MS - in Meeting Coverage, AAN from MedPage Today - http://t.co/hqQeZ52 from @medpagetoday
AAN 2011: Oral Cladribine Reduces Relapses in MS Patients Who Failed Injectable Therapies
hcplive.com — “Results from the CLARITY study show cladribine reduces the relapse rate in multiple sclerosis patients who have failed other disease-modifying therapies.” View full resource at hcplive.com
Most Recently Shared on April 14, 2011 at 2:01 pm By:
#AAN2011 CLARITY study shows #cladribine reduces relapse rate in injection-intolerant #multiplesclerosis patients http://hcp.lv/dPBXxT
Oral Drug for MS Significantly Reduces Disease Activity and Slows Disability
newswise.com — “The drug laquinimod reduced the number of relapses for people with multiple sclerosis (MS), in a large, long-term Phase III clinical study that will be presented as late-breaking research at the 63rd Annual Meeting of the American Academy of Neurology, April 9--16, 2011, in Honolulu.” View full resource at newswise.com
Most Recently Shared on April 12, 2011 at 1:10 am By:
Oral Drug for MS Significantly Reduces Disease Activity and Slows Disability: The drug laquinimod reduced the nu... http://bit.ly/gsq2iB
Medical News: AAN: Laquinimod Cuts Relapses, Progression in MS - in Meeting Coverage, AAN from MedPage Today
medpagetoday.com — “HONOLULU -- The investigational drug laquinimod, in development for treating relapsing-remitting multiple sclerosis, reduced the relapse rate as well as disease progression in a placebo-controlled pha” View full resource at medpagetoday.com
Most Recently Shared on April 11, 2011 at 11:26 pm By:
Laquinimod cuts relapses, progression in MS #AAN2011: http://bit.ly/gcTjTj
Medical News: AAN: Laquinimod Cuts Relapses, Progression in MS - in Meeting Coverage, AAN from MedPage Today
medpagetoday.com — “HONOLULU -- The investigational drug laquinimod, in development for treating relapsing-remitting multiple sclerosis, reduced the relapse rate as well as disease progression in a placebo-controlled pha” View full resource at medpagetoday.com
Most Recently Shared on April 11, 2011 at 9:45 pm By:
AAN: Laquinimod Cuts Relapses, Progression in MS http://bit.ly/hD8biU
Oral Drug for MS Significantly Reduces Disease Activity and Slows Disability
newswise.com — “The drug laquinimod reduced the number of relapses for people with multiple sclerosis (MS), in a large, long-term Phase III clinical study that will be presented as late-breaking research at the 63rd Annual Meeting of the American Academy of Neurology, April 9--16, 2011, in Honolulu.” View full resource at newswise.com
Most Recently Shared on April 11, 2011 at 9:40 pm By:
newswise Health Communicator and Health News
Oral Drug for MS Significantly Reduces Disease Activity and Slows Disability: The drug laquinimod reduced the nu... http://bit.ly/gajX3D
Oral drug for MS significantly reduces disease activity and slows disability
physorg.com — “The drug laquinimod reduced the number of relapses for people with multiple sclerosis (MS), in a large, long-term Phase III clinical study that will be presented as late-breaking research at the 63rd Annual Meeting of the American Academy of Neurology, April 9-16, 2011, in Honolulu.” View full resource at physorg.com
Most Recently Shared on April 11, 2011 at 9:00 pm By:
PhysOrg Health News Health News
Oral drug for MS significantly reduces disease activity and slows disability http://tw.physorg.com/221758418
Advertisement
